The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Labeled Nucleotides market was valued at US$ 2010 million in 2023 and is anticipated to reach US$ 3313.4 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
Labeled nucleotides are modified forms of nucleotides that have a specific chemical or radioactive label attached to them. These labels allow researchers to track, visualize, and detect specific nucleic acids in various molecular biology applications. Labeled nucleotides are commonly used in techniques such as DNA sequencing, PCR (polymerase chain reaction), in situ hybridization, DNA labeling, and nucleic acid microarray analysis.
Labeled nucleotides can be labeled with different types of labels, including fluorescent dyes, radioactive isotopes, or biotin. Fluorescently labeled nucleotides are widely used for fluorescence in situ hybridization (FISH), where they are incorporated into DNA or RNA probes to detect specific sequences in cells or tissues. These probes can be visualized under fluorescence microscopy, allowing for the visualization and localization of specific genetic sequences.
Radioactively labeled nucleotides, such as [32P]-labeled or [35S]-labeled nucleotides, are commonly used in techniques like DNA sequencing or autoradiography. Radioactive labels emit radiation that can be detected using specialized equipment or X-ray films, enabling the determination of nucleotide sequences or the detection of radiolabeled targets in biological samples.
Biotin-labeled nucleotides are frequently used in techniques like DNA labeling or nucleic acid microarray analysis. Biotin is a small molecule that can bind specifically to avidin or streptavidin, allowing for the indirect visualization or detection of the labeled nucleotide through the use of fluorescently or enzymatically labeled avidin/streptavidin conjugates.
The use of labeled nucleotides in molecular biology provides researchers with powerful tools for studying nucleic acids, gene expression, genetic variation, and various other molecular processes. The choice of label depends on the specific application, desired sensitivity, and detection method. Labeled nucleotides enable visualization, quantification, and analysis of nucleic acids, leading to a deeper understanding of genetic information and its role in biological processes.
This report aims to provide a comprehensive presentation of the global market for Labeled Nucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Labeled Nucleotides.
Report Scope
The Labeled Nucleotides market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Labeled Nucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Labeled Nucleotides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- Jena Bioscience
- Yumpu
- CJ CheilJedang Corporation
- Star Lake Bioscience
- ThermoFisher Scientific
- Meihua Group
- F. Hoffmann-La Roche
- Biorigin
- DSM Nutritional Products
- Promega Corporation
- Affymetrix
- Agilent Technologies
- Lallemand
- Nanjing BioTogether
Segment by Type
- TaqMan Allelic Discrimination
- Gene Chips & Microarrays
- SNP by Pyrosequencing
Segment by Application
- Hospital Laboratories
- Reference Laboratories
- Academic Research Laboratories
- Other Laboratories
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Labeled Nucleotides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Labeled Nucleotides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Labeled Nucleotides Market Overview
1.1 Product Overview and Scope of Labeled Nucleotides
1.2 Labeled Nucleotides Segment by Type
1.2.1 Global Labeled Nucleotides Market Value Comparison by Type (2024-2030)
1.2.2 TaqMan Allelic Discrimination
1.2.3 Gene Chips & Microarrays
1.2.4 SNP by Pyrosequencing
1.3 Labeled Nucleotides Segment by Application
1.3.1 Global Labeled Nucleotides Market Value by Application: (2024-2030)
1.3.2 Hospital Laboratories
1.3.3 Reference Laboratories
1.3.4 Academic Research Laboratories
1.3.5 Other Laboratories
1.4 Global Labeled Nucleotides Market Size Estimates and Forecasts
1.4.1 Global Labeled Nucleotides Revenue 2019-2030
1.4.2 Global Labeled Nucleotides Sales 2019-2030
1.4.3 Global Labeled Nucleotides Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Labeled Nucleotides Market Competition by Manufacturers
2.1 Global Labeled Nucleotides Sales Market Share by Manufacturers (2019-2024)
2.2 Global Labeled Nucleotides Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Labeled Nucleotides Average Price by Manufacturers (2019-2024)
2.4 Global Labeled Nucleotides Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Labeled Nucleotides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Labeled Nucleotides, Product Type & Application
2.7 Labeled Nucleotides Market Competitive Situation and Trends
2.7.1 Labeled Nucleotides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Labeled Nucleotides Players Market Share by Revenue
2.7.3 Global Labeled Nucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Labeled Nucleotides Retrospective Market Scenario by Region
3.1 Global Labeled Nucleotides Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Labeled Nucleotides Global Labeled Nucleotides Sales by Region: 2019-2030
3.2.1 Global Labeled Nucleotides Sales by Region: 2019-2024
3.2.2 Global Labeled Nucleotides Sales by Region: 2025-2030
3.3 Global Labeled Nucleotides Global Labeled Nucleotides Revenue by Region: 2019-2030
3.3.1 Global Labeled Nucleotides Revenue by Region: 2019-2024
3.3.2 Global Labeled Nucleotides Revenue by Region: 2025-2030
3.4 North America Labeled Nucleotides Market Facts & Figures by Country
3.4.1 North America Labeled Nucleotides Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Labeled Nucleotides Sales by Country (2019-2030)
3.4.3 North America Labeled Nucleotides Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Labeled Nucleotides Market Facts & Figures by Country
3.5.1 Europe Labeled Nucleotides Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Labeled Nucleotides Sales by Country (2019-2030)
3.5.3 Europe Labeled Nucleotides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Labeled Nucleotides Market Facts & Figures by Country
3.6.1 Asia Pacific Labeled Nucleotides Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Labeled Nucleotides Sales by Country (2019-2030)
3.6.3 Asia Pacific Labeled Nucleotides Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Labeled Nucleotides Market Facts & Figures by Country
3.7.1 Latin America Labeled Nucleotides Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Labeled Nucleotides Sales by Country (2019-2030)
3.7.3 Latin America Labeled Nucleotides Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Labeled Nucleotides Market Facts & Figures by Country
3.8.1 Middle East and Africa Labeled Nucleotides Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Labeled Nucleotides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Labeled Nucleotides Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Labeled Nucleotides Sales by Type (2019-2030)
4.1.1 Global Labeled Nucleotides Sales by Type (2019-2024)
4.1.2 Global Labeled Nucleotides Sales by Type (2025-2030)
4.1.3 Global Labeled Nucleotides Sales Market Share by Type (2019-2030)
4.2 Global Labeled Nucleotides Revenue by Type (2019-2030)
4.2.1 Global Labeled Nucleotides Revenue by Type (2019-2024)
4.2.2 Global Labeled Nucleotides Revenue by Type (2025-2030)
4.2.3 Global Labeled Nucleotides Revenue Market Share by Type (2019-2030)
4.3 Global Labeled Nucleotides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Labeled Nucleotides Sales by Application (2019-2030)
5.1.1 Global Labeled Nucleotides Sales by Application (2019-2024)
5.1.2 Global Labeled Nucleotides Sales by Application (2025-2030)
5.1.3 Global Labeled Nucleotides Sales Market Share by Application (2019-2030)
5.2 Global Labeled Nucleotides Revenue by Application (2019-2030)
5.2.1 Global Labeled Nucleotides Revenue by Application (2019-2024)
5.2.2 Global Labeled Nucleotides Revenue by Application (2025-2030)
5.2.3 Global Labeled Nucleotides Revenue Market Share by Application (2019-2030)
5.3 Global Labeled Nucleotides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Jena Bioscience
6.1.1 Jena Bioscience Corporation Information
6.1.2 Jena Bioscience Description and Business Overview
6.1.3 Jena Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jena Bioscience Labeled Nucleotides Product Portfolio
6.1.5 Jena Bioscience Recent Developments/Updates
6.2 Yumpu
6.2.1 Yumpu Corporation Information
6.2.2 Yumpu Description and Business Overview
6.2.3 Yumpu Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yumpu Labeled Nucleotides Product Portfolio
6.2.5 Yumpu Recent Developments/Updates
6.3 CJ CheilJedang Corporation
6.3.1 CJ CheilJedang Corporation Corporation Information
6.3.2 CJ CheilJedang Corporation Description and Business Overview
6.3.3 CJ CheilJedang Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CJ CheilJedang Corporation Labeled Nucleotides Product Portfolio
6.3.5 CJ CheilJedang Corporation Recent Developments/Updates
6.4 Star Lake Bioscience
6.4.1 Star Lake Bioscience Corporation Information
6.4.2 Star Lake Bioscience Description and Business Overview
6.4.3 Star Lake Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Star Lake Bioscience Labeled Nucleotides Product Portfolio
6.4.5 Star Lake Bioscience Recent Developments/Updates
6.5 ThermoFisher Scientific
6.5.1 ThermoFisher Scientific Corporation Information
6.5.2 ThermoFisher Scientific Description and Business Overview
6.5.3 ThermoFisher Scientific Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ThermoFisher Scientific Labeled Nucleotides Product Portfolio
6.5.5 ThermoFisher Scientific Recent Developments/Updates
6.6 Meihua Group
6.6.1 Meihua Group Corporation Information
6.6.2 Meihua Group Description and Business Overview
6.6.3 Meihua Group Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meihua Group Labeled Nucleotides Product Portfolio
6.6.5 Meihua Group Recent Developments/Updates
6.7 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche Labeled Nucleotides Product Portfolio
6.7.5 F. Hoffmann-La Roche Recent Developments/Updates
6.8 Biorigin
6.8.1 Biorigin Corporation Information
6.8.2 Biorigin Description and Business Overview
6.8.3 Biorigin Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biorigin Labeled Nucleotides Product Portfolio
6.8.5 Biorigin Recent Developments/Updates
6.9 DSM Nutritional Products
6.9.1 DSM Nutritional Products Corporation Information
6.9.2 DSM Nutritional Products Description and Business Overview
6.9.3 DSM Nutritional Products Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DSM Nutritional Products Labeled Nucleotides Product Portfolio
6.9.5 DSM Nutritional Products Recent Developments/Updates
6.10 Promega Corporation
6.10.1 Promega Corporation Corporation Information
6.10.2 Promega Corporation Description and Business Overview
6.10.3 Promega Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Promega Corporation Labeled Nucleotides Product Portfolio
6.10.5 Promega Corporation Recent Developments/Updates
6.11 Affymetrix
6.11.1 Affymetrix Corporation Information
6.11.2 Affymetrix Labeled Nucleotides Description and Business Overview
6.11.3 Affymetrix Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Affymetrix Labeled Nucleotides Product Portfolio
6.11.5 Affymetrix Recent Developments/Updates
6.12 Agilent Technologies
6.12.1 Agilent Technologies Corporation Information
6.12.2 Agilent Technologies Labeled Nucleotides Description and Business Overview
6.12.3 Agilent Technologies Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Agilent Technologies Labeled Nucleotides Product Portfolio
6.12.5 Agilent Technologies Recent Developments/Updates
6.13 Lallemand
6.13.1 Lallemand Corporation Information
6.13.2 Lallemand Labeled Nucleotides Description and Business Overview
6.13.3 Lallemand Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lallemand Labeled Nucleotides Product Portfolio
6.13.5 Lallemand Recent Developments/Updates
6.14 Nanjing BioTogether
6.14.1 Nanjing BioTogether Corporation Information
6.14.2 Nanjing BioTogether Labeled Nucleotides Description and Business Overview
6.14.3 Nanjing BioTogether Labeled Nucleotides Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nanjing BioTogether Labeled Nucleotides Product Portfolio
6.14.5 Nanjing BioTogether Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Labeled Nucleotides Industry Chain Analysis
7.2 Labeled Nucleotides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Labeled Nucleotides Production Mode & Process
7.4 Labeled Nucleotides Sales and Marketing
7.4.1 Labeled Nucleotides Sales Channels
7.4.2 Labeled Nucleotides Distributors
7.5 Labeled Nucleotides Customers
8 Labeled Nucleotides Market Dynamics
8.1 Labeled Nucleotides Industry Trends
8.2 Labeled Nucleotides Market Drivers
8.3 Labeled Nucleotides Market Challenges
8.4 Labeled Nucleotides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
